Adjuvant Pyrotinib and Capecitabine For HER2 Positive Micro Invasive Breast Cancer
NCT05861271
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
1008
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer Stage I
Interventions
DRUG:
Capecitabine，Pyrotinib
Sponsor
Fudan University